These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25098554)

  • 21. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
    Adeniji N; Dhanasekaran R
    Hepatol Commun; 2021 Dec; 5(12):1972-1986. PubMed ID: 34533885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
    Rivenbark AG; Coleman WB
    Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
    [No Abstract]   [Full Text] [Related]  

  • 25. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients.
    Abdelsameea E; Nada A; Omar N; Saleh SM; Naguib M; El-Ezawy HEM; Bakry L; Elsabaawy M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2259-2264. PubMed ID: 32856853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    Holmila R; Sklias A; Muller DC; Degli Esposti D; Guilloreau P; Mckay J; Sangrajrang S; Srivatanakul P; Hainaut P; Merle P; Herceg Z; Nogueira da Costa A
    PLoS One; 2017; 12(3):e0174265. PubMed ID: 28333958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.
    Dhayat SA; Yang Z
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1625-1645. PubMed ID: 32338295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
    Johnson P; Zhou Q; Dao DY; Lo YMD
    Nat Rev Gastroenterol Hepatol; 2022 Oct; 19(10):670-681. PubMed ID: 35676420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.
    Qi J; Wang J; Katayama H; Sen S; Liu SM
    Neoplasma; 2013; 60(2):135-42. PubMed ID: 23259781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma.
    Sarathi A; Palaniappan A
    BMC Cancer; 2019 Jul; 19(1):663. PubMed ID: 31277598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
    PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
    Li WX; Li Q; Lin Y; Huang YX; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
    Yan SY; Fan JG; Qio L
    Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
    Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
    Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
    Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
    Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.
    Stefanska B; Bouzelmat A; Huang J; Suderman M; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Szyf M
    PLoS One; 2013; 8(8):e68439. PubMed ID: 23950870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.